# Safety of Exposure to Natalizumab During Pregnancy

> **NCT05209815** · — · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 68 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BEHAVIORAL:** Questionnaire

## Key facts

- **NCT ID:** NCT05209815
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-20
- **Primary completion:** 2023-12-22
- **Final completion:** 2023-12-22
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05209815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05209815, "Safety of Exposure to Natalizumab During Pregnancy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05209815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*